1. Home
  2. JILL vs CRBU Comparison

JILL vs CRBU Comparison

Compare JILL & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo J. Jill Inc.

JILL

J. Jill Inc.

HOLD

Current Price

$16.92

Market Cap

233.1M

ML Signal

HOLD

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.46

Market Cap

203.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JILL
CRBU
Founded
1959
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
233.1M
203.9M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
JILL
CRBU
Price
$16.92
$1.46
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$18.50
$8.50
AVG Volume (30 Days)
122.2K
1.1M
Earning Date
12-10-2025
03-09-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
N/A
EPS
2.19
N/A
Revenue
$600,981,000.00
$9,295,000.00
Revenue This Year
N/A
$0.22
Revenue Next Year
$2.43
$4.48
P/E Ratio
$7.64
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.32
$0.66
52 Week High
$28.94
$3.54

Technical Indicators

Market Signals
Indicator
JILL
CRBU
Relative Strength Index (RSI) 70.78 34.21
Support Level $15.65 $1.52
Resistance Level $16.12 $1.63
Average True Range (ATR) 0.58 0.08
MACD 0.32 -0.00
Stochastic Oscillator 92.16 7.14

Price Performance

Historical Comparison
JILL
CRBU

About JILL J. Jill Inc.

J.Jill Inc is a national lifestyle brand that provides apparel, footwear, and accessories. The company's products are marketed under the J.Jill brand name and sold through its two channels: its e-commerce platform and catalog (Direct) and its retail stores (Retail). Revenue is derived from the sale of apparel and accessory merchandise through the company's Retail and Direct channels, which include website and catalog phone orders. Revenue also includes shipping and handling fees collected from customers.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Share on Social Networks: